BrightSpring Health Services (BTSG) vs Certara (CERT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
BrightSpring Health Services (BTSG) has outperformed Certara (CERT) over the past year, gaining 120.4% versus a loss of 33.5%. BrightSpring Health Services is the larger company by market cap ($12.60 billion vs $1.32 billion), about 9.6 times the size. On valuation, Certara trades at a lower forward P/E (22.2x vs 27.9x for BrightSpring Health Services).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTSG | CERT |
|---|---|---|
| Share price | $63.66 | $8.64 |
| Market cap | $12.60B | $1.32B |
| 1-day change | -0.22% | -3.57% |
| YTD return | +69.99% | -1.93% |
| 1-year return | +120.35% | -33.54% |
| 5-year return | — | -77.17% |
| P/E ratio (TTM) | 56.34 | — |
| Forward P/E | 27.94 | 22.17 |
| EPS (TTM) | $1.13 | $-0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $12.91B | — |
| Revenue growth (YoY) | +28.18% | — |
| Net income (latest FY) | $190.67M | — |
| Gross margin | 11.76% | — |
| Operating margin | 2.29% | — |
| Net margin | 1.48% | — |
| 52-week high | $73.75 | $13.11 |
| 52-week low | $27.30 | $4.45 |
| Distance from 52-week high | -13.68% | -34.10% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +24.00% | +0.81% |
| Average volume | 3.19M | 3.10M |
| Shares outstanding | 197.86M | 152.54M |
| Employees | 23,500 | 1,515 |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Health Information Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BrightSpring Health Services is about 9.6 times larger than Certara by market value ($12.60B vs $1.32B).
- BTSG has outperformed CERT by 153.9 percentage points over the past year.
About BrightSpring Health Services
BTSG stock →BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States.
Healthcare · Health Information Services · 23,500 employees
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Healthcare · Health Information Services · 1,515 employees
BTSG vs CERT FAQ
Which is bigger, BrightSpring Health Services or Certara?
BrightSpring Health Services (BTSG) is larger, with a market capitalization of $12.60B compared with $1.32B for Certara (CERT).
Which stock has performed better over the past year, BTSG or CERT?
BTSG returned +120.35% over the past 12 months, compared with -33.54% for CERT (price return, excluding dividends). Past performance does not predict future results.
Are BrightSpring Health Services and Certara in the same industry?
Yes. Both are classified in the Health Information Services industry within the Healthcare sector.